March 7, 2013
U.S. panel votes against calcitonin salmon bone drug
But other panelists said the drugs are an important option for patients who have bad reactions to newer drugs, including bisphosphonate drugs like Fosamax. “We have a whole lot of patients who can’t take the other drugs, and I think our patients would be in worse shape without this,” said Bart Clark, professor at the […]
Tags: calcitonin, CTV, Dr. Bart Clark, Fosamax, Mayo Clinic College of Medicine
March 6, 2013
FDA panel sees risk in long-used osteoporosis drug
A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer…”We have a whole lot of patients who can’t take the other drugs, and I think our patients would be in […]
Tags: bone strength, Dr. Bart Clark, federal health, MPR, osteoperosis, risk increase
version 3.3.6.2.7.4
Page loaded in 0.037 seconds